Kalamazoo County has implemented a new policy requiring employees to pay a monthly co-pay for GLP-1 weight loss medications. This move marks a change in how the county manages prescription drug coverage for its workforce. Officials cite rising costs as the primary driver for the adjustment to their health insurance offerings.
Under the updated rules, county employees taking these specific medications will now contribute to the cost of their prescriptions each month. The decision follows a trend among municipal employers who seek to balance employee benefits with the fiscal pressure of expensive specialty drugs. County leadership noted that expenditures for these medications grew significantly over the past year.
Health benefits remain a significant portion of the county budget. By shifting some of the financial burden for high-cost weight loss drugs to the users, the county aims to stabilize premiums for the wider workforce. Local government administrators acknowledge the difficulty of these decisions but emphasize that current spending levels were unsustainable.
Employees affected by the policy are now reviewing their coverage options. The change affects those on county-sponsored insurance plans who utilize GLP-1 treatments for weight loss rather than for diabetes management. The county continues to monitor health care spending to determine if further adjustments are necessary for the next fiscal cycle.